全文获取类型
收费全文 | 25944篇 |
免费 | 1694篇 |
国内免费 | 337篇 |
专业分类
耳鼻咽喉 | 578篇 |
儿科学 | 351篇 |
妇产科学 | 427篇 |
基础医学 | 4448篇 |
口腔科学 | 463篇 |
临床医学 | 2261篇 |
内科学 | 4846篇 |
皮肤病学 | 1058篇 |
神经病学 | 1693篇 |
特种医学 | 1796篇 |
外科学 | 3333篇 |
综合类 | 77篇 |
一般理论 | 11篇 |
预防医学 | 788篇 |
眼科学 | 680篇 |
药学 | 2666篇 |
中国医学 | 353篇 |
肿瘤学 | 2146篇 |
出版年
2023年 | 150篇 |
2022年 | 114篇 |
2021年 | 941篇 |
2020年 | 572篇 |
2019年 | 746篇 |
2018年 | 906篇 |
2017年 | 763篇 |
2016年 | 1060篇 |
2015年 | 1552篇 |
2014年 | 1761篇 |
2013年 | 1860篇 |
2012年 | 2743篇 |
2011年 | 2527篇 |
2010年 | 1581篇 |
2009年 | 1247篇 |
2008年 | 1655篇 |
2007年 | 1509篇 |
2006年 | 1355篇 |
2005年 | 1185篇 |
2004年 | 855篇 |
2003年 | 771篇 |
2002年 | 612篇 |
2001年 | 301篇 |
2000年 | 265篇 |
1999年 | 225篇 |
1998年 | 83篇 |
1997年 | 59篇 |
1996年 | 47篇 |
1995年 | 42篇 |
1994年 | 42篇 |
1993年 | 48篇 |
1992年 | 52篇 |
1991年 | 45篇 |
1990年 | 37篇 |
1989年 | 38篇 |
1988年 | 28篇 |
1987年 | 33篇 |
1986年 | 26篇 |
1985年 | 20篇 |
1984年 | 17篇 |
1983年 | 7篇 |
1982年 | 11篇 |
1981年 | 7篇 |
1979年 | 8篇 |
1978年 | 9篇 |
1977年 | 5篇 |
1976年 | 7篇 |
1974年 | 5篇 |
1969年 | 6篇 |
1968年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Hyun Cheol Chung MD PhD Yoon-Koo Kang MD PhD Zhendong Chen MD Yuxian Bai MD Wan Zamaniah Wan Ishak MD Byoung Yong Shim MD Young Lee Park MD Dong-Hoe Koo MD PhD Jianwei Lu MD Jianming Xu MD Hong Jae Chon MD Li-Yuan Bai MD Shan Zeng MD Ying Yuan MD Yen-Yang Chen MD Kangsheng Gu MD Wen Yan Zhong PhD Shu Kuang MD Chie-Schin Shih MD Shu-Kui Qin MD PhD 《Cancer》2022,128(5):995-1003
2.
Yoo Min Han Su Jin Chung Seokha Yoo Jong In Yang Ji Min Choi Jooyoung Lee Joo Sung Kim 《World journal of gastroenterology : WJG》2022,28(8):853-867
BACKGROUND Helicobacter pylori(H.pylori)infection is known to prevent the occurrence of gastroesophageal reflux disease(GERD)by inducing gastric mucosal atrophy.However,little is known about the relationship between atrophic gastritis(AG)and GERD.AIM To confirm the inverse correlation between AG and the occurrence and severity of GERD.METHODS Individuals receiving health checkups who underwent upper gastrointestinal endoscopy at Seoul National University Healthcare System Gangnam Center were included.The grade of reflux esophagitis was evaluated according to the Los Angeles classification.Endoscopic AG(EAG)was categorized into six grades.Serologic AG(SAG)was defined as pepsinogen I≤70 ng/m L and pepsinogen I/II ratio≤3.0.The association between the extent of EAG and SAG and the occurrence and severity of GERD was evaluated using multivariate logistic regression analysis.RESULTS In total,4684 individuals with GERD were compared with 21901 healthy controls.In multivariate logistic regression analysis,advanced age,male sex,body mass index>23 kg/m2,presence of metabolic syndrome,current smoking,and alcohol consumption were associated with an increased risk of GERD.Seropositivity for H.pylori immunoglobulin G antibodies was associated with a decreased risk of GERD.There was an inverse correlation between the extent of EAG and occurrence of GERD:Odds ratio(OR),1.01[95%confidence interval(CI):0.90-1.14]in C1,0.87(0.78-0.97)in C2,0.71(0.62-0.80)in C3,0.52(0.44-0.61)in O1,0.37(0.29-0.48)in O2,and 0.28(0.18-0.43)in O3.Additionally,the extent of EAG showed an inverse correlation with the severity of GERD.The presence of SAG was correlated with a reduced risk of GERD(OR=0.49,95%CI:0.28-0.87,P=0.014).CONCLUSION The extent of EAG and SAG exhibited strong inverse relationships with the occurrence and severity of GERD.AG followed by H.pylori infection may be independently protect against GERD. 相似文献
3.
4.
5.
6.
7.
J. Yoo F. Shah S. Velangi G. Stewart J. S. Scarisbrick 《Clinical and experimental dermatology》2019,44(4):414-417
Secukinumab is an interleukin (IL)‐17 monoclonal antibody inhibiting T‐helper (Th)1‐mediated immune response. It has proven high efficacy for moderate to severe psoriasis but data on its long‐term toxicities are limited. We describe two patients who received secukinumab for clinically presumed psoriasis, but were subsequently diagnosed with mycosis fungoides (MF) following skin biopsies triggered by skin deterioration while on secukinumab. Previous studies suggested decreased numbers of regulatory T cells (Tregs) with increasing stage of MF, which may lead to the shift in the Treg/Th17 balance towards the Th17 pathway. Theoretically, the use of IL‐17 monoclonal antibodies to inhibit Th17 pathway may lead to further immunosuppression and disease progression in cutaneous T‐cell lymphoma (CTCL) by shifting the balance towards Tregs, although this hypothesis has not been proven. With uncertainty over the role of IL‐17 and Treg/Th17 as well as diagnostic challenges in CTCL, we recommend that patients should have a confirmatory skin biopsy prior to the commencement of biologic therapy. 相似文献
8.
9.
10.